1. Home
  2. Labeler Index
  3. Gland Pharma Limited
  4. 68083-233
  5. NDC Package Code: 68083-233-06 Nelarabine

NDC Package 68083-233-06 Nelarabine

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68083-233-06
Package Description:
6 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE (68083-233-01)
Product Code:
68083-233
Proprietary Name:
Nelarabine
Non-Proprietary Name:
Nelarabine
Substance Name:
Nelarabine
Usage Information:
This medication is used to treat certain cancers (leukemia, lymphoma). Nelarabine is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
11-Digit NDC Billing Format:
68083023306
NDC to RxNorm Crosswalk:
  • RxCUI: 603566 - nelarabine 250 MG in 50 ML Injection
  • RxCUI: 603566 - 50 ML nelarabine 5 MG/ML Injection
  • RxCUI: 603566 - nelarabine 250 MG per 50 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Gland Pharma Limited
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • NELARABINE 5 mg/mL
    • Pharmacologic Class(es):
  • Nucleic Acid Synthesis Inhibitors - [MoA] (Mechanism of Action)
  • Nucleoside Metabolic Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA212605
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-03-2024
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68083-233-06?

    The NDC Packaged Code 68083-233-06 is assigned to a package of 6 vial, single-dose in 1 carton / 50 ml in 1 vial, single-dose (68083-233-01) of Nelarabine, a human prescription drug labeled by Gland Pharma Limited. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 68083-233 included in the NDC Directory?

    Yes, Nelarabine with product code 68083-233 is active and included in the NDC Directory. The product was first marketed by Gland Pharma Limited on January 03, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68083-233-06?

    The 11-digit format is 68083023306. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268083-233-065-4-268083-0233-06